End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-17 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
05-23 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 50.93M 69.62M |
---|---|---|---|---|---|
Net income 2022 | -4M -5.47M | Net income 2023 | -4M -5.47M | EV / Sales 2022 | - |
Net cash position 2022 | 85.4M 117M | Net cash position 2023 | 68.04M 93M | EV / Sales 2023 | - |
P/E ratio 2022 |
-8.53
x | P/E ratio 2023 |
-13.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.95% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 14-12-31 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 22-11-13 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Wayne Walker
BRD | Director/Board Member | 65 | 22-12-27 |
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+39.54% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.24% | 234B | |
+16.27% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |